Seattle's AVM Biotechnology Expands Executive Team in Preparation for Oncology and COVID-19 Clinical TrialsSEATTLE, WA, USA, July 8, 2020 /⁨EINPresswire.com⁩/ -- Seattle’s AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin’s Lymphoma and is …

#themarketindex [Collection]SEATTLE, WA, USA, July 8, 2020 /⁨EINPresswire.com⁩/ -- Seattle’s AVM Biotechnology, an up-and-coming biotech firm whose lead molecule, AVM0703, has received FDA permission to begin clinical trials treating no-option Non-Hodgkin’s Lymphoma and is …https://finance.einnews.com/pr_news/521210807/seattle-s-avm-biotechnology-expands-executive-team-in-preparation-for-oncology-and-covid-19-clinical-trials?ref=rss&ecode=LLcr_SPIiqTbik_F&utm_source=RSSNews&utm_medium=rss&utm_campaign=Finance+Industry+News&utm_content=article